The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

President Donald Trump baselessly blamed a diversity program for the crash. Meta CEO Mark Zuckerberg said the company is still committed to diversity.

Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...

Companies, consumers and farmers across North America braced on Friday for U.S. President Donald Trump to impose 25% tariffs ...

Discover the latest trends in the business world, from Barnes and Noble's growth fueled by BookTok to the FDA's approval of a new nonopioid pain medication.

Canada is lobbying the U.S. to show its commitment to border security to avoid tariffs. Officials shared videos of border ...

After two days of making his case to Senate committees, Robert F. Kennedy Jr.’s bid to lead federal health agencies still ...

The Trump administration plans to scrutinize scores of F.B.I. agents involved in Trump-related investigations, setting the stage for a possible purge targeting not only the bureau’s leaders but also ...